Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Expert Review of Gastroenterology & Hepatology|August 28, 2024
To STRIDE or not to STRIDE: a critique of "treat to target" in ulcerative colitisKlaus R Herrlinger, Eduard F StangeHepato-Gastroenterology|September 21, 2002
Symptomatic or asymptomatic gallstone disease: is the gallbladder motility the clue?Boris Brand, Lutz Lerche, Eduard F StangeGut Microbes|June 4, 2011
Paneth cell function--implications in pediatric Crohn diseaseJulia Beisner, Eduard F Stange, Jan WehkampInternational Journal of Inflammation|December 15, 2010
Antimicrobial peptides in gastrointestinal inflammationSimon Jäger, Eduard F Stange, Jan WehkampExpert Review of Anti-Infective Therapy|November 28, 2007
Host-microbe interaction: mechanisms of defensin deficiency in Crohn's diseaseGuoxing Wang, Eduard F Stange, Jan WehkampLangenbeck'S Archives of Surgery|November 20, 2012
Inflammatory bowel disease: an impaired barrier diseaseSimon Jäger, Eduard F Stange, Jan WehkampExpert Review of Clinical Immunology|September 11, 2010
Innate antimicrobial immunity in inflammatory bowel diseasesJulia Beisner, Eduard F Stange, Jan WehkampChemical Immunology and Allergy|June 25, 2005
Human defensins in Crohn's diseaseJan Wehkamp, Klaus Fellermann, Eduard F StangeDigestive Diseases (Basel, Switzerland)|November 20, 2013
Defective antibacterial barrier in inflammatory bowel diseaseThomas Klag, Eduard F Stange, Jan WehkampCurrent Opinion in Gastroenterology|June 5, 2007
Defensins and other antimicrobial peptides in inflammatory bowel diseaseJan Wehkamp, Michael Schmid, Eduard F StangePageof 11